Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency
Louis J. Muglia, … , Toshihiro Suda, Joseph A. Majzoub
Louis J. Muglia, … , Toshihiro Suda, Joseph A. Majzoub
Published May 1, 2000
Citation Information: J Clin Invest. 2000;105(9):1269-1277. https://doi.org/10.1172/JCI5250.
View: Text | PDF
Article

Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency

Abstract

Corticotropin-releasing hormone (CRH)–deficient (KO) mice provide a unique system to define the role of CRH in regulation of the hypothalamic-pituitary-adrenal (HPA) axis. Despite several manifestations of chronic glucocorticoid insufficiency, basal pituitary proopiomelanocortin (POMC) mRNA, adrenocorticotrophic hormone (ACTH) peptide content within the pituitary, and plasma ACTH concentrations are not elevated in CRH KO mice. The normal POMC mRNA content in KO mice is dependent upon residual glucocorticoid secretion, as it increases in both KO and WT mice after adrenalectomy; this increase is reversed by glucocorticoid, but not aldosterone, replacement. However, the normal plasma levels of ACTH in CRH KO mice are not dependent upon residual glucocorticoid secretion, because, after adrenalectomy, these levels do not undergo the normal increase seen in KO mice despite the increase in POMC mRNA content. Administration of CRH restores ACTH secretion to its expected high level in adrenalectomized CRH KO mice. Thus, in adrenal insufficiency, loss of glucocorticoid feedback by itself can increase POMC gene expression in the pituitary; but CRH action is essential for this to result in increased secretion of ACTH. This may explain why, after withdrawal of chronic glucocorticoid treatment, reactivation of CRH secretion is a necessary prerequisite for recovery from suppression of the HPA axis.

Authors

Louis J. Muglia, Lauren Jacobson, Christina Luedke, Sherri K. Vogt, Michele L. Schaefer, Pieter Dikkes, Shoko Fukuda, Yoko Sakai, Toshihiro Suda, Joseph A. Majzoub

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
Stimulation of the HPA axis by CRH (a–d) or vasopressin (e and f) in WT ...
Stimulation of the HPA axis by CRH (a–d) or vasopressin (e and f) in WT and CRH KO mice. Time course for plasma ACTH is shown for sham-adrenalectomized (sham) or adrenalectomized mice supplemented with constant-release corticosterone pellets delivering double the physiologic replacement (ADX + 2XB) (a), and for adrenalectomized (ADX) mice (b), after intraperitoneal injection of 90 μg/kg CRH. Respective time courses for plasma corticosterone are shown for the mice in a (c) and b (d). Plasma ACTH (e) and corticosterone (f) after injection of vehicle or VP. Plasma ACTH increases to a similar extent in KO and WT mice after VP compared with vehicle injection, although only the WT mice demonstrate a significant increase in plasma corticosterone.